Individuals with obesity who undergo bariatric surgery are much less likely to develop type 2 diabetes mellitus than are those receiving routine care, new findings reveal. Intriguingly, baseline data on surrogate measures of insulin resistance rather than BMI were predictive of the preventive effect of surgery on type 2 diabetes mellitus.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
Scientific Reports Open Access 01 February 2023
-
Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery
Current Atherosclerosis Reports Open Access 09 February 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Carlsson, L. M. et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N. Engl. J. Med. 367, 695–704 (2012).
Rubino, F., Schauer, P. R., Kaplan, L. M. & Cummings, D. E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu. Rev. Med. 61, 393–411 (2010).
Adams, T. D. et al. Long-term mortality after gastric bypass surgery. N. Engl. J. Med. 357, 753–761 (2007).
Dixon, J. B. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299, 316–323 (2008).
Mingrone, G. et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. 366, 1577–1585 (2012).
Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N. Engl. J. Med. 366, 1567–1576 (2012).
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N. Engl. J. Med. 361, 445–454 (2009).
Rubino, R., Kaplan, L. M., Schauer, P. R. & Cummings, D. E. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann. Surg. 251, 399–405 (2010).
Zimmet, P., Alberti, K. G., Rubino, F. & Dixon, J. B. IDF's view of bariatric surgery in type 2 diabetes. Lancet 378, 108–110 (2011).
Rubino, F. et al. Bariatric, metabolic and diabetes surgery: what's in a name? Ann. Surg. (in press).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
F. Rubino declares associations with the following companies: Covidien (research grant), NGM Biopharmaceuticals (scientific advisory board). D. E. Cummings declares associations with the following companies: Johnson & Johnson (grant/research support).
Rights and permissions
About this article
Cite this article
Rubino, F., Cummings, D. The coming of age of metabolic surgery. Nat Rev Endocrinol 8, 702–704 (2012). https://doi.org/10.1038/nrendo.2012.207
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2012.207
This article is cited by
-
Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
Scientific Reports (2023)
-
Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain
Obesity Surgery (2020)
-
RYGB Produces more Sustained Body Weight Loss and Improvement of Glycemic Control Compared with VSG in the Diet-Induced Obese Mouse Model
Obesity Surgery (2017)
-
Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery
Current Atherosclerosis Reports (2017)
-
Bariatric and metabolic surgery: a shift in eligibility and success criteria
Nature Reviews Endocrinology (2015)